Versant Venture Management, LLC Repare Therapeutics Inc. Transaction History
Versant Venture Management, LLC
- $38.2 Million
- Q3 2024
A detailed history of Versant Venture Management, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 2,646,657 shares of RPTX stock, worth $3.57 Million. This represents 23.86% of its overall portfolio holdings.
Number of Shares
2,646,657
Previous 2,646,657
-0.0%
Holding current value
$3.57 Million
Previous $8.73 Million
4.25%
% of portfolio
23.86%
Previous 19.39%
Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
62Shares Held
35.4MCall Options Held
50KPut Options Held
300-
Bvf Inc San Francisco, CA10.3MShares$14 Million1.13% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$4.55 Million3.82% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.49 Million0.27% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.01 Million17.66% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.51MShares$3.39 Million0.08% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $56.6M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...